SCHEMBL30337196

SCHEMBL30337196

CCOC(=O)c1cnc(Cl)nc1-c1cn(C)c2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.55
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 3/20 0.46
MAPT P10636 3/20 0.46
LMNA P02545 2/20 0.46
MAPK1 P28482 1/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
CNR1 P21554 1/20 0.42
USP2 O75604 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17384785 1.00 EGFR (0.55) EGFRKMT2AMEN1ALDH1A1MAPT
SCHEMBL17373094 0.88 NR4A2 (0.55) EGFRKMT2AMEN1ALDH1A1CDK5
SCHEMBL19103249 0.85 EGFR (0.55) EGFRKMT2AMEN1ALDH1A1CDK5
SCHEMBL30239416 0.83 EGFR (0.50) EGFRKMT2AMEN1ALDH1A1MAPT
SCHEMBL2951237 0.79 ALDH1A1 (0.55) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL14719082 0.78 CDK5 (0.52) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL30052020 0.78 CDK5 (0.52) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL25497122 0.77 CDK5 (0.49) KMT2AMEN1ALDH1A1LMNACDK5
SCHEMBL17542583 0.77 EGFR (0.49) EGFRKMT2AMEN1ALDH1A1LMNA
SCHEMBL30337269 0.77 EGFR (0.49) EGFRKMT2AMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974845-B Preparation method of Ornitinib intermediate 奥锐特药业股份有限公司 2024-09-20 CN disclosed
CN-115974845-A Preparation method of oxitinib intermediate 奥锐特药业股份有限公司 2023-04-18 CN disclosed